A novel conditional gene silencing method using a tumor-specific and heat-inducible siRNA system

被引:3
|
作者
Feng, Jing [1 ]
Wang, Xiaoyu [1 ]
Liao, Yi [1 ]
Feng, Jianguo [1 ]
Tang, Liling [1 ]
机构
[1] Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Coll Bioengn, Chongqing 400044, Peoples R China
关键词
HTERT promoter; HSE; SiRNA; Heat-shock; Gene silence; SMALL-INTERFERING-RNA; BREAST-CANCER CELLS; MAMMALIAN-CELLS; EXPRESSION SYSTEM; LENTIVIRAL VECTOR; PROMOTER REGION; IN-VITRO; INHIBITION; THERAPY; STRESS;
D O I
10.1007/s10295-016-1759-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
RNAi technology is an invaluable tool for investigating gene function. However, the non-temporal and non-spatial control is the primary limitation, which leads to siRNA leakiness and off-target effects. In this study, we inserted three kinds of HSE into tumor specific promoter hTERT, which aims to construct a temperature-inducible and tumor-specific RNAi plasmid vector. In our system, the expression of mature siRNA is tightly controlled by the heat shock-inducible and tumor-specific promoters. From the expression level of RNA and protein, we determined the efficiency of the inducible siRNA system by targeting SNCG gene in HepG2 and MCF-7 cells. Results showed that the controllable siRNA system could be induced to initiate siRNA expression by heat-induce. The silencing effect of SNCG is on a relative low level (10 %) at 37 A degrees C, while it is significantly increased to 50 or 60 % after heat inducing at 43 A degrees C. This new conditional siRNA system provides a novel approach to drive the siRNA expression by heat-inducible and tumor-specific promoter.
引用
收藏
页码:761 / 770
页数:10
相关论文
共 50 条
  • [41] Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA
    Duong, Connie
    Chen, Cathy
    Yoshida, Sakiko
    Barisone, Gustavo
    Nolta, Jan
    Diaz, Elva
    Nitin, Nitin
    Satake, Noriko
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
    Hatakeyama, H.
    Akita, H.
    Kogure, K.
    Oishi, M.
    Nagasaki, Y.
    Kihira, Y.
    Ueno, M.
    Kobayashi, H.
    Kikuchi, H.
    Harashima, H.
    GENE THERAPY, 2007, 14 (01) : 68 - 77
  • [43] Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
    Hatakeyama, Hiroto
    Akita, Hidetaka
    Kogure, Kentaro
    Harashima, Hideyoshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (10): : 1549 - 1556
  • [44] Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
    H Hatakeyama
    H Akita
    K Kogure
    M Oishi
    Y Nagasaki
    Y Kihira
    M Ueno
    H Kobayashi
    H Kikuchi
    H Harashima
    Gene Therapy, 2007, 14 : 68 - 77
  • [45] siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions
    K Iwamura
    T Kato
    Y Miyahara
    H Naota
    J Mineno
    H Ikeda
    H Shiku
    Gene Therapy, 2012, 19 : 959 - 966
  • [46] Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins
    Boden, D
    Pusch, O
    Silbermann, R
    Lee, F
    Tucker, L
    Ramratnam, B
    NUCLEIC ACIDS RESEARCH, 2004, 32 (03) : 1154 - 1158
  • [47] siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions
    Iwamura, K.
    Kato, T.
    Miyahara, Y.
    Naota, H.
    Mineno, J.
    Ikeda, H.
    Shiku, H.
    GENE THERAPY, 2012, 19 (10) : 959 - 966
  • [48] A novel in vivo siRNA delivery technology for dendritic cell-specific gene silencing and immune modulation
    Vladau, Costin
    Zheng, Xiufen
    Zhang, Xusheng
    Li, Mu
    Suzuki, Motohiko
    Chen, Dong
    Garcia, Bertha
    Min, Wei-Ping
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [49] Identification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene delivery
    Ho, IAW
    Lam, PYP
    Hui, KM
    CANCER GENE THERAPY, 2004, 11 (12) : 853 - 853
  • [50] Experimental gene therapy using tumor-specific replicating adenovirus vectors.
    Fukuda, K
    Abei, M
    Ugai, H
    Yokoyama, K
    Tanaka, N
    GASTROENTEROLOGY, 2002, 122 (04) : A407 - A407